+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Small Molecule Innovator CDMO Global Market Report 2024

  • PDF Icon

    Report

  • 175 Pages
  • February 2024
  • Region: Global
  • The Business Research Company
  • ID: 5940032
The small molecule innovator cdmo market size has grown strongly in recent years. It will grow from $51.84 billion in 2023 to $56.13 billion in 2024 at a compound annual growth rate (CAGR) of 8.3%. The growth observed in the historical period can be attributed to factors such as the rising demand for outsourcing services, the increasing complexity of small molecule drugs, a heightened focus on reducing time-to-market, cost pressures on pharmaceutical companies, and the need to comply with stringent regulatory requirements.

The small molecule innovator cdmo market size is expected to see strong growth in the next few years. It will grow to $76.46 billion in 2028 at a compound annual growth rate (CAGR) of 8.0%. The anticipated growth in the forecast period can be attributed to factors such as the rise in personalized medicine and targeted therapies, an increased focus on green chemistry and sustainability, the demand for faster time-to-market for new drugs, the expansion of the biopharmaceutical pipeline, and the emergence of advanced therapies. Key trends expected in the forecast period encompass the rise of virtual and remote development models, increased collaboration and partnerships in the pharmaceutical industry, the expansion of CDMO services to emerging markets, the utilization of single-use technologies in manufacturing, and the evolution of CDMOs into strategic development partners.

The growth of the small-molecule innovator CDMO market is expected to be fueled by the increasing prevalence of chronic diseases. Chronic diseases, which last a year or longer and often require continuous medical care, are on the rise. The small-molecule innovator CDMO market plays a crucial role in manufacturing medicines for chronic diseases, providing services to pharmaceutical and biotech companies. Projections from the National Center for Biotechnology Information (NCBI) in January 2023 indicate that by 2050, the number of individuals aged 50 and older with at least one chronic illness in the US is anticipated to surge by 99.5%, reaching 142.66 million, up from 71.522 million in 2020. Thus, the increasing prevalence of chronic diseases serves as a driving force for the small-molecule innovator CDMO market.

A factor expected to contribute to the growth of the small-molecule innovator CDMO market is the rising expenditures on research and development (R&D). Research and Development expenditures involve financial resources allocated by companies or organizations for activities aimed at innovation, product development, and technological advancements. The small-molecule innovator CDMO market supports increased R&D spending by offering specialized and efficient services to pharmaceutical and biotechnology companies, facilitating expedited drug discovery and development processes. Notably, in January 2023, the National Center for Science and Engineering Statistics (NCSES) reported a substantial increase in R&D expenditures in the US, reaching $717 billion in 2020 and an estimated rise to $792 billion in 2021. A significant portion of these expenditures, totaling $471.7 billion, was directed towards experimental development, constituting 66% of the total R&D spending. Therefore, the upward trajectory of R&D expenditures is a driving factor for the small-molecule innovator CDMO market.

A prominent trend in the small-molecule CDMO market is the focus on product innovation. Major companies within this market are adopting innovative products to sustain their positions. In May 2023, Oxford Biomedica, a UK-based company, introduced TetraVecta, a next-generation system for CDMO. This technology addresses previous challenges in medicinal development related to payload size, complexity, or interference, thereby facilitating the advancement of in vivo gene treatments.

Strategic partnerships are emerging as a key approach for major companies in the small-molecule innovator CDMO market to provide contract development and manufacturing organization (CDMO) services. Strategic partnerships involve leveraging each other's strengths and resources for mutual benefits and success. An example of this approach is the partnership between SST Corporation, a US-based pharmaceutical company, and Viwit Pharmaceuticals, a China-based research-based pharmaceutical and chemical company. Through this collaboration, they aim to enhance market growth in North America by expanding offerings, leveraging expertise, increasing capacity, and providing essential regulatory support to strengthen their competitive edge.

In February 2022, Recipharma AB, a Sweden-based pharmaceutical CDMO, acquired Vibalogics for an undisclosed amount. This acquisition allows Recipharm to utilize Vibalogics' expertise in oncolytic viruses, viral vaccines, and viral vector gene treatments, enabling diversification across multiple technologies and modalities. Vibalogics GmbH is a Germany-based pharmaceutical CDMO.

Major companies operating in the small molecule innovator cdmo market report are Thermo Fisher Scientific Inc., Boehringer Ingelheim International GmbH, Evonik Industries AG, Lonza Group Ltd. , Labcorp Drug Development, Catalent Inc., Wuxi AppTec Co. Ltd., Asymchem, Siegfried holdings, Recipharm AB, Almac Sciences Ltd., Curia Global Inc., Cambrex Corporation, Piramal Pharma Ltd., Hovione, Corden Pharma GmbH, Alcami Corporation, Lifecore Biomedical Inc., NovaTech LLC, Mikart LLC, Kymanox Corporation, August Bioservices LLC, Lyophilization Technology Inc., LGM Pharma LLC, INCOG BioPharma Services.

Asia-Pacific was the largest region in the small molecule innovator CDMO market in 2023. The regions covered in the small molecule innovator cdmo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the small molecule innovator cdmo market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The main product types offered by small molecule innovator CDMOs include small molecule active pharmaceutical ingredient (API) and small molecule drug product. Small molecule API refers to any material or combination of materials intended to be used as an active component in the production of a medication or medical product. The various stages involved in the development and manufacturing process include preclinical, clinical, and commercial stages, and these products are used in therapeutic areas such as cardiovascular disease, oncology, respiratory disorders, neurology, metabolic disorders, infectious disease, and others. The primary customers for small molecule innovator CDMOs are pharmaceutical and biotechnology companies.

The small molecule innovator CDMO market research report is one of a series of new reports that provides small molecule innovator CDMO market statistics, including small molecule innovator CDMO industry global market size, regional shares, competitors with a small molecule innovator CDMO market share, detailed small molecule innovator CDMO market segments, market trends and opportunities, and any further data you may need to thrive in the small molecule innovator CDMO industry. This small molecule innovator CDMO market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The small molecule innovator CDMO market includes revenues earned by entities by manufacturing the drug substance and providing innovation and services such as packaging, serialization, and shipment. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Small Molecule Innovator CDMO Market Characteristics3. Small Molecule Innovator CDMO Market Trends and Strategies
4. Small Molecule Innovator CDMO Market - Macro Economic Scenario
4.1. Impact of High Inflation on the Market
4.2. Ukraine-Russia War Impact on the Market
4.3. COVID-19 Impact on the Market
5. Global Small Molecule Innovator CDMO Market Size and Growth
5.1. Global Small Molecule Innovator CDMO Market Drivers and Restraints
5.1.1. Drivers of the Market
5.1.2. Restraints of the Market
5.2. Global Small Molecule Innovator CDMO Historic Market Size and Growth, 2018-2023, Value ($ Billion)
5.3. Global Small Molecule Innovator CDMO Forecast Market Size and Growth, 2023-2028, 2033F, Value ($ Billion)
6. Small Molecule Innovator CDMO Market Segmentation
6.1. Global Small Molecule Innovator CDMO Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Small Molecule Active Pharmaceutical Ingredient(API)
  • Small Molecule Drug Product
6.2. Global Small Molecule Innovator CDMO Market, Segmentation by Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Preclinical
  • Clinical
  • Commercial
6.3. Global Small Molecule Innovator CDMO Market, Segmentation by Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cardiovascular Disease
  • Oncology
  • Respiratory Disorders
  • Neurology
  • Metabolic Disorders
  • Infectious Disease
  • Other Therapeutics
6.4. Global Small Molecule Innovator CDMO Market, Segmentation by Customer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical
  • Biotechnology
7. Small Molecule Innovator CDMO Market Regional and Country Analysis
7.1. Global Small Molecule Innovator CDMO Market, Split by Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Small Molecule Innovator CDMO Market, Split by Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Small Molecule Innovator CDMO Market
8.1. Asia-Pacific Small Molecule Innovator CDMO Market Overview
Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Small Molecule Innovator CDMO Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Small Molecule Innovator CDMO Market, Segmentation by Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Small Molecule Innovator CDMO Market, Segmentation by Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Small Molecule Innovator CDMO Market
9.1. China Small Molecule Innovator CDMO Market Overview
9.2. China Small Molecule Innovator CDMO Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Small Molecule Innovator CDMO Market, Segmentation by Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Small Molecule Innovator CDMO Market, Segmentation by Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Small Molecule Innovator CDMO Market
10.1. India Small Molecule Innovator CDMO Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Small Molecule Innovator CDMO Market, Segmentation by Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Small Molecule Innovator CDMO Market, Segmentation by Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Small Molecule Innovator CDMO Market
11.1. Japan Small Molecule Innovator CDMO Market Overview
11.2. Japan Small Molecule Innovator CDMO Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Small Molecule Innovator CDMO Market, Segmentation by Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Small Molecule Innovator CDMO Market, Segmentation by Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Small Molecule Innovator CDMO Market
12.1. Australia Small Molecule Innovator CDMO Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Small Molecule Innovator CDMO Market, Segmentation by Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Small Molecule Innovator CDMO Market, Segmentation by Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Small Molecule Innovator CDMO Market
13.1. Indonesia Small Molecule Innovator CDMO Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Small Molecule Innovator CDMO Market, Segmentation by Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Small Molecule Innovator CDMO Market, Segmentation by Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Small Molecule Innovator CDMO Market
14.1. South Korea Small Molecule Innovator CDMO Market Overview
14.2. South Korea Small Molecule Innovator CDMO Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Small Molecule Innovator CDMO Market, Segmentation by Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Small Molecule Innovator CDMO Market, Segmentation by Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Small Molecule Innovator CDMO Market
15.1. Western Europe Small Molecule Innovator CDMO Market Overview
15.2. Western Europe Small Molecule Innovator CDMO Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Small Molecule Innovator CDMO Market, Segmentation by Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Small Molecule Innovator CDMO Market, Segmentation by Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Small Molecule Innovator CDMO Market
16.1. UK Small Molecule Innovator CDMO Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Small Molecule Innovator CDMO Market, Segmentation by Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Small Molecule Innovator CDMO Market, Segmentation by Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Small Molecule Innovator CDMO Market
17.1. Germany Small Molecule Innovator CDMO Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Small Molecule Innovator CDMO Market, Segmentation by Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Small Molecule Innovator CDMO Market, Segmentation by Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Small Molecule Innovator CDMO Market
18.1. France Small Molecule Innovator CDMO Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Small Molecule Innovator CDMO Market, Segmentation by Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Small Molecule Innovator CDMO Market, Segmentation by Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Small Molecule Innovator CDMO Market
19.1. Italy Small Molecule Innovator CDMO Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Small Molecule Innovator CDMO Market, Segmentation by Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Small Molecule Innovator CDMO Market, Segmentation by Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Small Molecule Innovator CDMO Market
20.1. Spain Small Molecule Innovator CDMO Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Small Molecule Innovator CDMO Market, Segmentation by Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Small Molecule Innovator CDMO Market, Segmentation by Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Small Molecule Innovator CDMO Market
21.1. Eastern Europe Small Molecule Innovator CDMO Market Overview
21.2. Eastern Europe Small Molecule Innovator CDMO Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Small Molecule Innovator CDMO Market, Segmentation by Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Small Molecule Innovator CDMO Market, Segmentation by Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Small Molecule Innovator CDMO Market
22.1. Russia Small Molecule Innovator CDMO Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Small Molecule Innovator CDMO Market, Segmentation by Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Small Molecule Innovator CDMO Market, Segmentation by Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Small Molecule Innovator CDMO Market
23.1. North America Small Molecule Innovator CDMO Market Overview
23.2. North America Small Molecule Innovator CDMO Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Small Molecule Innovator CDMO Market, Segmentation by Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Small Molecule Innovator CDMO Market, Segmentation by Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Small Molecule Innovator CDMO Market
24.1. USA Small Molecule Innovator CDMO Market Overview
24.2. USA Small Molecule Innovator CDMO Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Small Molecule Innovator CDMO Market, Segmentation by Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Small Molecule Innovator CDMO Market, Segmentation by Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Small Molecule Innovator CDMO Market
25.1. Canada Small Molecule Innovator CDMO Market Overview
25.2. Canada Small Molecule Innovator CDMO Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Small Molecule Innovator CDMO Market, Segmentation by Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Small Molecule Innovator CDMO Market, Segmentation by Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Small Molecule Innovator CDMO Market
26.1. South America Small Molecule Innovator CDMO Market Overview
26.2. South America Small Molecule Innovator CDMO Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Small Molecule Innovator CDMO Market, Segmentation by Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Small Molecule Innovator CDMO Market, Segmentation by Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Small Molecule Innovator CDMO Market
27.1. Brazil Small Molecule Innovator CDMO Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Small Molecule Innovator CDMO Market, Segmentation by Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Small Molecule Innovator CDMO Market, Segmentation by Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Small Molecule Innovator CDMO Market
28.1. Middle East Small Molecule Innovator CDMO Market Overview
28.2. Middle East Small Molecule Innovator CDMO Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Small Molecule Innovator CDMO Market, Segmentation by Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Small Molecule Innovator CDMO Market, Segmentation by Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Small Molecule Innovator CDMO Market
29.1. Africa Small Molecule Innovator CDMO Market Overview
29.2. Africa Small Molecule Innovator CDMO Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Small Molecule Innovator CDMO Market, Segmentation by Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Small Molecule Innovator CDMO Market, Segmentation by Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Small Molecule Innovator CDMO Market Competitive Landscape and Company Profiles
30.1. Small Molecule Innovator CDMO Market Competitive Landscape
30.2. Small Molecule Innovator CDMO Market Company Profiles
30.2.1. Thermo Fisher Scientific Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Boehringer Ingelheim International GmbH
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Evonik Industries AG
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Lonza Group Ltd.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Labcorp Drug Development
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Small Molecule Innovator CDMO Market Other Major and Innovative Companies
31.1. Catalent Inc.
31.2. Wuxi AppTec Co. Ltd.
31.3. Asymchem
31.4. Siegfried holdings
31.5. Recipharm AB
31.6. Almac Sciences Ltd.
31.7. Curia Global Inc.
31.8. Cambrex Corporation
31.9. Piramal Pharma Ltd.
31.10. Hovione
31.11. Corden Pharma GmbH
31.12. Alcami Corporation
31.13. Lifecore Biomedical Inc.
31.14. NovaTech LLC
31.15. Mikart LLC
32. Global Small Molecule Innovator CDMO Market Competitive Benchmarking33. Global Small Molecule Innovator CDMO Market Competitive Dashboard34. Key Mergers and Acquisitions in the Small Molecule Innovator CDMO Market
35. Small Molecule Innovator CDMO Market Future Outlook and Potential Analysis
35.1 Small Molecule Innovator CDMO Market in 2028 - Countries Offering Most New Opportunities
35.2 Small Molecule Innovator CDMO Market in 2028 - Segments Offering Most New Opportunities
35.3 Small Molecule Innovator CDMO Market in 2028 - Growth Strategies
35.3.1 Market Trend-based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic and Forecast Inflation Rates
36.4. Research Inquiries
36.5. About the Analyst
36.6. Copyright and Disclaimer

Executive Summary

Small Molecule Innovator CDMO Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on small molecule innovator cdmo market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia-Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis.
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for small molecule innovator cdmo? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of COVID-19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Report Scope

Markets Covered:
1) By Product: Small Molecule Active Pharmaceutical Ingredient (API); Small Molecule Drug Product
2) By Stage: Preclinical; Clinical; Commercial
3) By Therapeutic: Cardiovascular Disease; Oncology; Respiratory Disorders; Neurology; Metabolic Disorders; Infectious Disease; Other Therapeutics
4) By Customer: Pharmaceutical; Biotechnology

Key Companies Mentioned: Thermo Fisher Scientific Inc.; Boehringer Ingelheim International GmbH; Evonik Industries AG; Lonza Group Ltd. ; Labcorp Drug Development

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes

Delivery Format: PDF, Word and Excel Data Dashboard

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Thermo Fisher Scientific Inc.
  • Boehringer Ingelheim International GmbH
  • Evonik Industries AG
  • Lonza Group Ltd.
  • Labcorp Drug Development
  • Catalent Inc.
  • Wuxi AppTec Co. Ltd.
  • Asymchem
  • Siegfried holdings
  • Recipharm AB
  • Almac Sciences Ltd.
  • Curia Global Inc.
  • Cambrex Corporation
  • Piramal Pharma Ltd.
  • Hovione
  • Corden Pharma GmbH
  • Alcami Corporation
  • Lifecore Biomedical Inc.
  • NovaTech LLC
  • Mikart LLC
  • Kymanox Corporation
  • August Bioservices LLC
  • Lyophilization Technology Inc.
  • LGM Pharma LLC
  • INCOG BioPharma Services

Methodology

Loading
LOADING...

Table Information